Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 3 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 10 hours agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 4 days agoThey have tips on what you need to know this season. (Getty Images) Vera Vita via Getty Images It’s...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 3 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
FDA reverses course, calls for vaccines for fall 2024 to target newer COVID-19 strain
AOL· 3 days agoThe Food and Drug Administration provided updated guidance for COVID-19 vaccine makers, calling for...
Here are 7 things Arizonans need to know about the new KP.3 variant of COVID-19
The Arizona Republic· 6 days agoA new variant of COVID-19 called KP.3 is on the rise in the U.S. and has been detected in Arizona....
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA TODAY via Yahoo News· 4 days agoThe updated vaccines are set to be released in the fall, ahead of expected winter upticks in COVID-19 cases. Contributing ...
There’s A New COVID Variant, KP.3 – These Are The Symptoms
IFLScience· 3 days agoKP.3 is one of the FLiRT variants of SARS-CoV-2. The immune system can learn to recognize spike...
COVID cases rising in L.A. County and California as new subvariants make mark
Los Angeles Times· 5 days agoCalifornia’s COVID-19 numbers are on the rise thanks in part to new subvariants, suggesting an...
FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases
Center for Infectious Disease Research and Policy· 3 days agoShortly after, the FDA accepted the advisers' advice but said it would continue to monitor the...